Effect of CV159-Ca2+/Calmodulin Blockade on Redox Status Hepatic Ischemia-Reperfusion Injury in Mice Evaluated by a Newly Developed In Vivo EPR Imaging Technique

Journal of Surgical Research

Volumn 147, Issue 1, 2008, Pages 41-49

  Kobayashi, Hiromichi P ^a   Watanabe, Taiji ^a   Oowada, Shigeru ^a   Hirayama, Aki ^b   Nagase, Sohji ^b   Kamibayashi, Masato ^c   Otsubo, Takehito ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Ca2+ calmodulin blockade; CV159; electron paramagnetic resonance imaging (EPRI); hepatic I R injury

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 4 (3 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID 3 METHYL 5 [6 (5 PHENYL 3 PYRAZOLYLOXY)HEXYL] ESTER; ALANINE AMINOTRANSFERASE; CALCIUM ION; CALMODULIN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; IMAGING SYSTEM; IN VIVO STUDY; LIVER ISCHEMIA; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; CALCIUM; CALMODULIN; DIHYDROPYRIDINES; ELECTRON SPIN RESONANCE SPECTROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 43049113890     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.06.024     Document Type: Article

References (32)

1. Rost D., Welker A., Welker J., et al. Liver-homing of purified glucorse oxidase: a novel in vivo model of physiological hepatic oxidative stress (H(2)O(2)). J Hepatol 46 (2006) 482
2. Halliwell B., and Gutteridge J.N. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol 186 (1990) 1
3. Takahashi K., Saito K., Ueda J., et al. Kinetic study on ESR signal decay of nitroxyl radicals, potent redox probes for in vivo ESR spectroscopy, caused by reactive oxygen species. Biochim Biophys Acta 1573 (2002) 156
4. Yoshida M., Saegusa Y., Fukuda A., et al. Measurement of radical-scavenging ability in hepatic metallothionein of rat using in vivo electron spin resonance spectroscopy. Toxicology 213 (2005) 74
5. Togashi H., Shinzawa H., and Matsuo T. Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Radic Biol Med 28 (2000) 846
6. Couet W.R., Brasch R.C., Sosnovsky C., et al. Factors affecting nitroxide reduction in ascorbate solution and tissue homogenate. Magn Reson Imaging 3 (1985) 83
7. Hirayama A., Yoh K., Nagase S., et al. EPR imaging of reducing activity in Nrf2 transcriptional factor deficient mice. Free Radic Biol Med 34 (2003) 1236
8. Umekawa H., Yamakawa K., Nunoki K., et al. Inhibition of calmodulin function by CV159, a novel dihydropyridine compound. Biochem Pharmacol 37 (1988) 3377
9. Miyazaki H., Tanaka S., Fujii Y., et al. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV-159), on rat ischemic brain injury. Life Sci 64 (1999) 869
10. Berkel R., Egink G., Marsen T.A., et al. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanism. Hypertension 37 (2001) 240
11. 2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells. J Cardiovasc Pharmacol 47 (2006) 314
12. 2+ antagonist, CV159, in hepatic IR injury-the evaluation of hepatic organ reducing activity using in vivo and ex vivo EPR. J Surg Res (in press) 2007.
13. Kamibayashi M., Oowada S., Kameda H., et al. Synthesis and characterization of practically better DEPMPO-type spin trap, 5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide (CYPMPO). Free Radic Res 40 (2006) 1166
14. Watanabe T., Kubota S., Nagaya M., et al. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 124 (2005) 59
15. Nedergaard J., and Cannon B. Overview, preparation and properties of mitochondria from different sources. Methods Enzymol 55 (1979) 3
16. Fleischer S., Mcintyer J.O., and Vidal J.C. Large scale preparation of rat liver mitochondria. Methods Enzymol 55 (1979) 32
17. Watanabe T., Owada S., Kobayashi P.H., et al. Measurement of radical-scavenging ability in small bowel ischemia/reperfusion injury in rats using an in vivo and ex vivo electron paramagnetic resonance technique. Transplant Proc 39 (2007) 253
18. Lee M.-C., Shoji H., Miyazaki H., et al. Assessment of oxidative stress in the spontaneously hypertensive rat brain using electron spin resonance (ESR) imaging and in vivo L-band ESR. Hypertens Res 27 (2004) 485
19. Miura Y., and Ozawa T. Noninvasive study of radiation-induced oxidative damage using in vivo electron spin resonance. Free Radic Biol Med 28 (2000) 854
20. Hirayama A., and Nagase S. Electron paramagnetic resonance imaging of oxidative stress in renal disease. Nephron Clin Pract 103 (2006) 71
21. Yamagishi S., Inagaki Y., Nakamura K., et al. A newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells though its anti-oxidative properties. J Cardiovasc Pharmacol 43 (2004) 724
22. Mason R.P. Mechanism of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence. Atherosclerosis 165 (2002) 191
23. Chen L., Haught W.H., Yang B., et al. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 30 (1997) 569
24. Zhou M.S., Jaimes E.A., and Raij L. Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 17 (2004) 167
25. Catalioto R.M., Renzetti A.R., Criscuoli M., et al. Role of calcium in angiotensin II-induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells. J Cardiovasc Pharmacol 27 (1996) 195
26. Waypa G.B., Marks J.D., Mack M.M., et al. Mitochondria reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res 91 (2002) 719
27. Hongpaisan J., Winters C.A., and Andrews S.B. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci 24 (2004) 10878
28. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579
29. Yellon D.M. Myocardial postconditioning:reperfusion injury revisited. Am J Physiol Heart Circ Physiol 289 (2005) H3
30. Kai S., Zhi-Su L., and Quan S. Role of mitochondria in cell apotosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol 10 (2004) 1934
31. Andrew T., Derek J.H., Mihaela M.M., et al. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95 (2004) 230
32. Tissier R., Waintraub X., Couvreur N., et al. Pharmacological postconditioning with the phytoestrogen genistein. J Mol Cell Cardiol 42 (2007) 79